Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc [More Details]

Medical Professionals Become an LDN Specialist [More Details]

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis

Biomedicines
As revised 23 March 2023
https://www.mdpi.com/2227-9059/11/4/1087

 

Jenny - US: LDN, CRPS and Small Fibre Neuropathy (LDN; low dose naltrexone)

 

Off-label pharmacological treatment for neuropathic pain: A Delphi study by the Spanish Pain Society Neuropathic Pain Task Force

Pain Pract
29 October 2022
https://pubmed.ncbi.nlm.nih.gov/36308490/

 

Natasha - Australia: Chronic Pain and Cancer (LDN; low dose naltrexone)

 

 

The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details